Author:
Khaled Boushra,Alzahayqa Mahmoud,Jaffal Ahmad,Sallam Husam,Thawabta Rua’a,Mansour Mamoun,Alian Akram,Salah Zaidoun
Abstract
Abstract
Background
Congenital insensitivity to pain (CIP) is a rare autosomal recessive disorder characterized primarily by an inability to perceive physical pain from birth, resulting in the accumulation of bruising, inflammation, and fractures that affect patient’s life expectancy. CIP has different forms including CIP and CIPA. CIP with Anhidrosis (CIPA) is the most common type of CIP, which is caused mainly by mutations in NTRK1 and NGF genes, and is characterized by mental retardation and the inability to sweat (Anhidrosis). Because of high consanguinity rates in Palestine, this rare disease appears to have a higher frequency than in other communities. However, there were no systematic studies to address the genetic factors that cause CIP in the Palestinian community.
Methods
In our study, we used Sanger and Whole exome sequencing to genotype members of five CIP-affected Palestinian families.
Results
Our results confirm the presence of the founder c.1860-1861insT mutation in the NTRK1 gene of Palestinian Bedouin CIPA patients. Furthermore, one CIPA family carried a missense c.2170 G > A (G724 S) mutation in exon 16 of the NTRK1 gene. Finally, a novel nonsense c.901 A > T mutation (K301*) was detected in exon 7 of the SCN9A gene in CIP without anhidrosis family.
Conclusions
Our study revealed three mutations that cause CIP and CIPA in the Palestinian community, which can help in improving the process of diagnosis and genetic counseling and establishing protocols for the diagnosis and follow-up for the affected individuals. This is especially important given that early diagnosis and medical care interference can prevent unpleasant CIP and CIPA complications.
Funder
Arab American University of Jenin
Medicare laboratories, Palestine
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference26 articles.
1. Drissi I, Woods WA, Woods CG. Understanding the genetic basis of congenital insensitivity to pain. Br Med Bull. 2020;133(1):65–78.
2. Sun J, Li L, Yang L, Duan G, Ma T, Li N, et al. Novel SCN9A missense mutations contribute to congenital insensitivity to pain: unexpected correlation between electrophysiological characterization and clinical phenotype. Mol Pain. 2020;16:1744806920923881.
3. Schon KR, Parker APJ, Woods CG et al. Congenital Insensitivity to Pain Overview. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, editors. GeneReviews((R)). Seattle (WA)1993.
4. Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV. Clinical, biological and molecular aspects of mutations in TRKA(NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin Auton Res. 2002;12(Suppl 1):I20–32.
5. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444(7121):894–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献